Journal
VASCULAR MEDICINE
Volume 27, Issue 5, Pages 496-512Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1358863X221122552
Keywords
cardiac risk index; major adverse cardiovascular events; major vascular surgery; perioperative management; pre-operative evaluation
Categories
Ask authors/readers for more resources
Risk stratification prior to major vascular surgery plays a crucial role in predicting perioperative major adverse cardiovascular events (MACE). Comorbidities such as coronary artery disease, heart failure, left-sided valvular heart disease, and significant arrhythmic burden are associated with higher risk of perioperative MACE. Different cardiac risk indices, noninvasive and invasive cardiac testing, and perioperative pharmacotherapies have strengths and weaknesses in predicting risk.
Patients undergoing major vascular surgery have an increased risk of perioperative major adverse cardiovascular events (MACE). Accordingly, in this population, it is of particular importance to appropriately risk stratify patients' risk for these complications and optimize risk factors prior to surgical intervention. Comorbidities that portend a higher risk of perioperative MACE include coronary artery disease, heart failure, left-sided valvular heart disease, and significant arrhythmic burden. In this review, we provide a current approach to risk stratification prior to major vascular surgery and describe the strengths and weaknesses of different cardiac risk indices; discuss the role of noninvasive and invasive cardiac testing; and review perioperative pharmacotherapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available